Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. appears in FDA public data with 1 recall, 0 510(k) clearances, 2 FDA inspections, and 0 compliance actions on record. Its most recent recall (Z-2653-2023, Class II) was initiated on August 22, 2023.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 2
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| Z-2653-2023 | Class II | Apellis Injection Kit 29g Injection Needle -single use intended to inject fluids into, or withdraw f | August 22, 2023 |